Company Filing History:
2 out of 90 
1 out of 295 
1 out of 3,539 
Years Active: 2019-2020
Title: The Innovative Mind of Christian A Hassig
Introduction
Christian A Hassig, based in La Jolla, California, is a distinguished inventor known for his significant contributions to the field of biopharmaceuticals. With a total of two patents to his name, he has made groundbreaking advancements that have the potential to impact various medical treatments and research areas.
Latest Patents
Hassig’s latest patents showcase his expertise and innovative mindset. The first patent is for "Quinolinones as inhibitors of translation initiation complex," which covers compounds and pharmaceutical compositions comprising quinolinones. These compounds have demonstrated utility as modulators of the eukaryotic translation initiation factor 4F (eIF4F) complex. The second patent, "Inhibitors of glucocorticoid receptor translocation," details compounds and compositions useful as modulators of Glucocorticoid Receptor (GR) translocation. These innovations are particularly relevant for treating diseases related to the hypothalamic-pituitary-adrenal (HPA) axis.
Career Highlights
Christian A Hassig has worked at prestigious institutions, including Sanford Burnham Prebys Medical Discovery Institute and The Royal Institution for the Advancement of Learning/McGill University. His tenure at these institutions has enabled him to engage in cutting-edge research, leading to significant inventions that address critical health issues.
Collaborations
Throughout his career, Hassig has collaborated with notable peers such as Anthony B Pinkerton and Ze'ev Ronai. These collaborations have fostered a creative and productive environment conducive to scientific innovation, contributing to the successful development of his patents.
Conclusion
Christian A Hassig stands out as a prominent inventor in the biopharmaceutical sector. His innovative patents reflect an ongoing commitment to advancing medical science and improving healthcare outcomes. As he continues to explore new frontiers in research and development, the impact of his work is likely to be felt in the medical community for years to come.